BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
PRODUCTS ON MARKET: Services:
DNA sequencing
Genotyping
Microbial species analysis: Species composition of unculturables, species
identification of cultivated organisms
Screening assay development
Preparation of HTS extracts for small molecular screening (pharma,
cosmetics)
Discovery and development of extremophilic genes and enzymes
Provision of test samples
Prometic BioSciences Inc.
155 Willowbrook Boulevard, Suite 460
Wayne NJ 07470, US
Phone: (973) 812-9880; Fax: (973) 812-9881
Toll-free phone: (888) 472-4225
Web: www.prometic.com
E-mail: investor@prometic.com
KEY PERSONNEL: Pierre Laurin; Chairman, President and CEO, Prometic Life Sciences Inc.
Steven J. Burton; CEO, Prometic BioSciences Ltd.
Christopher L. Penney; VP and CSO, Therapeutics
EMPLOYEES: 75 employees
HISTORY: Founded in October 1994
Began biotech R&D in 1995
Acquired Affinity Chromatography Ltd. UK
Member--Biotechnology Industry Organization
STOCK-FINANCIAL HISTORY: Privately held by parent
SUBSIDIARY OF: Prometic Life Sciences Inc. (see separate entry)
BUSINESS STRATEGY: Discover and develop proprietary drugs in the fields of cancer and
autoimmune diseases
Actively looking for partners to co-develop and eventually market PBI-1402
and PBI-1393
AGREEMENTS: Name Products Content of Agreement Date
American Red
Cross
prion removal/det collaborative R&D 1999
American Red plasma proteins collaborative R&D 1997
Cross
agreement
BioMena SA ProMetic's Enabling
Technology
licensing agreement 12/04
Euroflow process columns large scale process
data
2003
GlaxoSmithKline Prometic's purification development 7/04
plc
technology
agreement
Menarini purification of avidiplas R&D manufacture
agreement
2001
Novo Nordisk
University of
Cambridge UK
proteins collaborative R&D 1995
Octapharma AG ProMetic's advanced development 1/05
Mimetic Ligand affinity
technology for
Octapharma protein
product
agreement
Copyright ©2006 AHC Media ® 330